查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650961

凝膠電泳的全球市場

Gel Electrophoresis
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球凝膠電泳市場規模將達到 25 億美元

2024 年全球凝膠電泳市場規模估計為 19 億美元，預計 2030 年將達到 25 億美元，2024 年至 2030 年的複合年成長率為 5.3%。實驗室研究最終用途是報告中分析的細分市場之一，預計複合年成長率為 5.3%，到分析期結束時將達到 12 億美元。在分析期內，製藥和生物技術最終用途部門的複合年成長率預計為 5.8%。

美國市場規模估計為 4.828 億美元，中國市場預計複合年成長率為 8.2%

預計到 2024 年美國凝膠電泳市場價值將達到 4.828 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 5.752 億美元，在 2024 年至 2030 年的分析期間內，複合年成長率為 8.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.1% 和 4.2%。在歐洲，德國的複合年成長率預計為 3.8%。

全球凝膠電泳市場-主要趨勢與促進因素摘要

為什麼凝膠電泳對現代分子生物學和研究至關重要？

凝膠電泳是分子生物學和生物化學中的一項基本技術，在核酸（DNA、RNA）和蛋白質的分析和分離中起著重要作用。但為什麼這項技術在現代科學研究中如此重要？凝膠電泳至關重要，因為它允許科學家根據分子的大小、電荷和形狀分離分子，讓他們能夠精確地觀察、量化和分析遺傳物質和蛋白質。該技術廣泛應用於從基因指紋識別和法醫學分析到基因克隆、基因工程和蛋白質研究等各種應用領域。

在 DNA 分析中，凝膠電泳對於確認聚合酵素鏈鎖反應(PCR) 和限制性酶消化的成功尤其重要，這是基因研究和分子克隆中必不可少的步驟。研究人員利用它來確認 DNA 片段的存在、大小和完整性，從而能夠繪製基因圖譜、研究基因突變或在法醫學案件中識別個體。在蛋白質研究中，凝膠電泳有助於確定蛋白質的純度、分子量和結構，這對於藥物開發和診斷應用至關重要。由於其多功能性和精確度，凝膠電泳仍然是分子生物學研究的基石，推動了基因組學、蛋白質組學和個人化醫療的突破性進展。

科技進步如何增強凝膠電泳技術？

凝膠電泳技術的進步極大地提高了它的準確性、速度和易用性，使其成為分子生物學和生物化學研究的更強大的工具。一項重大技術創新是自動電泳系統的開發。這些系統將從樣品加載到成像的所有電泳步驟整合為一個簡化的自動化流程。自動化系統可減少人為錯誤，提供一致的結果，並允許同時分析多個樣本，從而提高實驗室的吞吐量和效率。

另一項重大進步是凝膠材料的改進。雖然傳統的瓊脂糖和聚丙烯醯胺凝膠仍被廣泛使用，但正在開發具有更好解析度和更快運行時間的新型凝膠。例如，預製凝膠是預先製備的，這樣研究人員就不必自己準備凝膠。預製凝膠的厚度和成分也更均勻，確保更準確和可重複的結果。此外，不同密度的梯度凝膠的開發使得同一樣品中不同大小的分子能夠更精確地分離，從而提高結果的透明度。

螢光染色技術是凝膠電泳的另一項突破。溴化乙錠等傳統染色劑已被更安全、更靈敏的螢光染料所取代，能夠檢測出更少量的核酸和蛋白質。這些染料會與感興趣的分子結合，並在特定波長的光照射下發出明亮的螢光訊號，從而可以輕鬆檢測到微量的物質。這種靈敏度在次世代定序和蛋白質體學等需要準確定量的應用中尤其有價值。

此外，電泳緩衝液和溫度控制系統等操作條件的進步有助於防止分離過程中敏感生物分子的劣化，進一步提高了凝膠電泳的可靠性。這些創新使得凝膠電泳更加強大、準確且易於使用，擴大了其在基因組學、蛋白質組學和分子診斷等前沿研究領域的應用。

為什麼凝膠電泳對於研究和診斷 DNA、RNA 和蛋白質至關重要？

凝膠電泳對於 DNA、RNA 和蛋白質的分析至關重要，特別是在精確度和準確度至關重要的研究和診斷應用中。在 DNA 和 RNA 分析中，凝膠電泳可以依大小分離核酸。這對於 PCR 或限制性酶消化等技術後可視化遺傳物質至關重要。透過這種分離，研究人員可以確認特定 DNA 或 RNA 片段的存在，評估其品質並確定其大小——這是基因圖譜、克隆和序列測定的關鍵因素。在法醫學中，凝膠電泳也用於 DNA 指紋識別，其中 DNA 片段的獨特模式可用於識別個人或建立關係。

在蛋白質研究中，凝膠電泳對於分析蛋白質組成、結構和功能至關重要。 SDS-PAGE（十二烷基硫酸鈉聚丙烯醯胺凝膠電泳）等技術可根據蛋白質的分子量分離蛋白質，使科學家能夠研究複雜混合物中的單一蛋白質。這對於藥物開發至關重要，研究人員需要分離和研究涉及疾病途徑的特定蛋白質。凝膠電泳也用於評估蛋白質純度和檢測轉譯後修飾。這些對於生化研究和治療藥物開發非常重要。

此外，凝膠電泳在遺傳疾病、癌症、感染疾病的診斷中也有重要作用。例如，它通常用於識別與囊腫纖維化和鐮狀細胞性貧血等疾病相關的基因突變。透過分離和分析患者樣本中的 DNA 和 RNA，臨床醫生可以精確定位特定的基因異常，從而做出準確的診斷和個人化的治療方案。此外，基於電泳的技術（例如西方印漬術）也用於臨床診斷，以檢測與疾病相關的蛋白質，例如自體免疫疾病中的抗體和愛滋病毒等感染疾病中的病毒蛋白。

摘要，它是一種在研究和診斷領域提供高精度分離和分析生物分子能力的基本工具。它在處理核酸和蛋白質方面的多功能性和有效性使其成為增進我們對遺傳學、疾病機制和藥物開發的理解的關鍵技術。

哪些因素推動了凝膠電泳市場的成長？

由於對分子診斷的需求不斷增加、基因組研究的進步以及對更高效和精確的測試技術的需求，凝膠電泳市場正在經歷強勁成長。其中一個主要促進因素是基因組學和蛋白​​質組學領域的擴展，它們廣泛使用電泳法分析 DNA、RNA 和蛋白質。隨著研究人員對基因表現研究、基因圖譜和個人化醫療的深入研究，對凝膠電泳等可靠、準確的技術的需求持續成長。

其次，對分子診斷的不斷成長的需求正在推動市場成長。隨著遺傳疾病、癌症和感染疾病變得越來越普遍，醫療保健提供者正在轉向分子診斷技術來準確識別和治療這些疾病。凝膠電泳通常用於診斷，以檢測基因突變、識別傳染源和監測疾病進展。隨著精準醫療成為醫療保健領域的標準方法，對精確的 DNA、RNA 和蛋白質分析的需求推動了電泳技術在臨床環境中的應用。

第三，電泳系統的技術進步使得該技術更容易取得、更快捷、更易於使用。自動化凝膠電泳系統、預製凝膠和先進的成像技術降低了傳統電泳過程的複雜性和所需的時間，鼓勵更多的研究人員和臨床醫生採用這項技術。這些創新也提高了結果的準確性和可重複性，這對於診斷、藥物開發和研究應用至關重要。

此外，對個人化醫療和生物標記發現的日益關注也促進了凝膠電泳市場的成長。當研究人員尋求識別與疾病相關的特定遺傳標記或蛋白質特徵時，凝膠電泳仍然是分離和可視化這些生物分子的關鍵技術。例如，在癌症研究中，電泳用於研究蛋白質表現模式和識別潛在的治療目標，從而推動了對先進電泳系統的需求。

此外，政府對生命科學研究的資助和投資也進一步推動了市場成長。許多國家都在其醫療保健和研究舉措中大力投資基因組研究和分子診斷，從而導致學術、臨床和製藥實驗室擴大採用凝膠電泳技術。

總之，由於對分子研究的需求不斷增加、診斷技術的進步、個人化醫療的需求以及更快、更有效率的電泳系統的發展，凝膠電泳市場正在成長。隨著這些趨勢的持續，凝膠電泳將繼續成為研究和臨床實驗室的基石技術，並將在促進我們對分子生物學的理解和改善醫療保健結果方面發揮關鍵作用。

部分

最終用戶（實驗室研究、製藥和生物技術公司以及其他最終用戶）

受訪企業範例（共41家）

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CBS Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12153

Global Gel Electrophoresis Market to Reach US$2.5 Billion by 2030

The global market for Gel Electrophoresis estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Pharma & Biotech Companies End-Use segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$482.8 Million While China is Forecast to Grow at 8.2% CAGR

The Gel Electrophoresis market in the U.S. is estimated at US$482.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Gel Electrophoresis Market - Key Trends and Drivers Summarized

Why Is Gel Electrophoresis Critical in Modern Molecular Biology and Research?

Gel electrophoresis is a fundamental technique in molecular biology and biochemistry, playing a vital role in the analysis and separation of nucleic acids (DNA, RNA) and proteins. But why is this technique so crucial in modern scientific research? Gel electrophoresis is essential because it allows scientists to separate molecules based on their size, charge, or shape, making it possible to visualize, quantify, and analyze genetic material and proteins with precision. This technique is widely used in a range of applications, from genetic fingerprinting and forensic analysis to gene cloning, genetic engineering, and protein research.

In DNA analysis, gel electrophoresis is particularly important for verifying the success of polymerase chain reactions (PCR) or restriction enzyme digestion, which are essential steps in genetic studies and molecular cloning. Researchers use it to confirm the presence, size, and integrity of DNA fragments, enabling them to map genes, study genetic mutations, or even identify individuals in forensic cases. In protein studies, gel electrophoresis helps in determining the purity, molecular weight, and structure of proteins, making it indispensable for drug development and diagnostic applications. Given its versatility and precision, gel electrophoresis remains a cornerstone of molecular biology research, enabling breakthroughs in genomics, proteomics, and personalized medicine.

How Are Technological Advancements Enhancing Gel Electrophoresis?

Technological advancements in gel electrophoresis are significantly improving its precision, speed, and ease of use, making it an even more powerful tool for molecular and biochemical research. One of the key innovations is the development of automated electrophoresis systems. These systems integrate all the steps of electrophoresis—from sample loading to imaging—into a streamlined, automated process. Automated systems reduce human error, provide consistent results, and allow researchers to analyze multiple samples simultaneously, improving throughput and efficiency in laboratories.

Another major advancement is the improvement in gel materials. Traditional agarose and polyacrylamide gels are still widely used, but newer gels have been developed with better resolution and faster run times. For example, precast gels come pre-prepared, eliminating the need for researchers to prepare their own gels, which can be time-consuming and error-prone. Precast gels also offer more uniformity in thickness and composition, ensuring more accurate and reproducible results. Additionally, the development of gradient gels, which vary in density, allows for more precise separation of molecules of different sizes in the same sample, improving the clarity of results.

Fluorescent staining techniques represent another breakthrough in gel electrophoresis. Traditional stains like ethidium bromide have been largely replaced by safer and more sensitive fluorescent dyes that can detect much smaller quantities of nucleic acids and proteins. These dyes bind to the molecules of interest and, when exposed to specific wavelengths of light, produce a bright fluorescent signal, making it easier to detect even trace amounts of material. This sensitivity is particularly valuable in applications like next-generation sequencing or proteomics, where precise quantification is essential.

Additionally, advancements in electrophoresis buffers and running conditions, such as temperature-controlled systems, help prevent the degradation of sensitive biomolecules during the separation process, further improving the reliability of gel electrophoresis. These technological innovations are making gel electrophoresis more robust, accurate, and user-friendly, expanding its use in cutting-edge research fields such as genomics, proteomics, and molecular diagnostics.

Why Is Gel Electrophoresis Essential for DNA, RNA, and Protein Analysis in Research and Diagnostics?

Gel electrophoresis is indispensable for the analysis of DNA, RNA, and proteins, particularly in research and diagnostic settings where precision and accuracy are paramount. For DNA and RNA analysis, gel electrophoresis allows scientists to separate nucleic acids by size, which is crucial for visualizing genetic material after techniques like PCR or restriction enzyme digestion. This separation helps researchers confirm the presence of specific DNA or RNA fragments, assess their quality, and determine their size—key factors in gene mapping, cloning, and sequencing. In forensic science, gel electrophoresis is also used for DNA fingerprinting, where the unique patterns of DNA fragments can be used to identify individuals or verify relationships.

In protein research, gel electrophoresis is essential for analyzing protein composition, structure, and function. Techniques like SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) allow proteins to be separated based on their molecular weight, enabling scientists to study individual proteins in complex mixtures. This is critical for drug development, where researchers need to isolate and study specific proteins involved in disease pathways. Gel electrophoresis is also used to assess protein purity and to detect post-translational modifications, both of which are important in biochemical research and the development of therapeutics.

Moreover, gel electrophoresis plays a vital role in diagnosing genetic disorders, cancers, and infections. For example, it is commonly used to identify mutations in genes that are linked to diseases like cystic fibrosis or sickle cell anemia. By separating and analyzing DNA or RNA from patient samples, clinicians can pinpoint specific genetic abnormalities, allowing for accurate diagnosis and personalized treatment plans. Additionally, electrophoresis-based techniques like Western blotting are used in clinical diagnostics to detect proteins associated with diseases, such as antibodies in autoimmune disorders or viral proteins in infections like HIV.

In summary, gel electrophoresis is a fundamental tool in both research and diagnostics, providing the ability to separate and analyze biological molecules with a high degree of precision. Its versatility and effectiveness in handling nucleic acids and proteins make it a critical technique for advancing our understanding of genetics, disease mechanisms, and drug development.

What Factors Are Driving the Growth of the Gel Electrophoresis Market?

The gel electrophoresis market is experiencing strong growth, driven by a combination of increasing demand for molecular diagnostics, advancements in genomic research, and the need for more efficient and precise laboratory techniques. One of the primary drivers is the expanding field of genomics and proteomics, which relies heavily on electrophoresis for DNA, RNA, and protein analysis. As researchers delve deeper into gene expression studies, genetic mapping, and personalized medicine, the demand for reliable and accurate techniques like gel electrophoresis continues to rise.

Second, the growing need for molecular diagnostics is fueling market growth. With the increasing prevalence of genetic disorders, cancers, and infectious diseases, healthcare providers are turning to molecular diagnostic techniques to accurately identify and treat these conditions. Gel electrophoresis is commonly used in diagnostics to detect genetic mutations, identify infectious agents, and monitor the progression of diseases. As precision medicine becomes a standard approach in healthcare, the need for accurate DNA, RNA, and protein analysis is driving the adoption of electrophoresis technologies in clinical settings.

Third, technological advancements in electrophoresis systems are making the technique more accessible, faster, and easier to use. Automated gel electrophoresis systems, pre-cast gels, and advanced imaging techniques are reducing the complexity and time required for traditional electrophoresis processes, attracting more researchers and clinicians to adopt this technology. These innovations are also improving the accuracy and reproducibility of results, which is essential for applications in diagnostics, drug development, and research.

Additionally, the increasing focus on personalized medicine and biomarker discovery is contributing to the growth of the gel electrophoresis market. As researchers seek to identify specific genetic markers or protein signatures linked to diseases, gel electrophoresis remains a key technique for separating and visualizing these biomolecules. In cancer research, for example, electrophoresis is used to study protein expression patterns and identify potential therapeutic targets, driving the demand for advanced electrophoresis systems.

Moreover, government funding and investments in life science research are further propelling market growth. Many countries are investing heavily in genomics research and molecular diagnostics as part of their healthcare and research initiatives, leading to greater adoption of gel electrophoresis technologies in academic, clinical, and pharmaceutical laboratories.

In conclusion, the gel electrophoresis market is growing due to the rising demand for molecular research, advancements in diagnostic technologies, the need for personalized medicine, and the development of faster, more efficient electrophoresis systems. As these trends continue, gel electrophoresis will remain a cornerstone technique in both research and clinical laboratories, playing a critical role in advancing our understanding of molecular biology and improving healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the Gel Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Laboratory Research, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • C.B.S. Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Gel Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Gel Electrophoresis in Genomics and Proteomics Drives Market Growth
    • Role of Gel Electrophoresis in Drug Discovery and Development Processes
    • Market Opportunities in Emerging Biotechnology Markets
    • Consumer Demand for Faster, More Accurate Diagnostic Techniques
    • Advances in Microfluidics and Miniaturization of Electrophoresis Equipment
    • Environmental and Safety Considerations in Electrophoresis Media Disposal
    • Role of Gel Electrophoresis in Quality Control in Food and Beverage Industry
    • Future Trends: Towards Chip-based Electrophoresis and Lab-on-a-Chip Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Laboratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION